Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07095426 · ClinicalTrials.gov registry record · NA
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
A NA study of Healthy Participants and Metabolic Syndrome, sponsored by Ball State University.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07095426: Recruiting NA study of Healthy Participants and Metabolic Syndrome, sponsored by Ball State University.
NCT07095426 is a NA study of Healthy Participants and Metabolic Syndrome that is actively recruiting participants, run by Ball State University. The registered enrollment target is 20 participants, below the 65-participant average among 119 other Healthy Participants trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07095426, a NA study of Healthy Participants and Metabolic Syndrome, is actively recruiting participants, sponsored by Ball State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Based on prior research, the investigators are interested in whether an intervention targeting gut health (supplemental fiber for 9 weeks total) will improve vascular health in individuals with obesity. Additionally, the investigators are interested in if this response differs based on whether individuals with obesity have very few heart disease risk factors or several heart disease risk factors.
Primary Outcome
The investigators will measure fasting sCD14 at each visit. These measurements will take place immediately and a complete dataset will be compiled upon study completion.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT inulin
Study Locations (1)
Indiana
- Health Professions Building - Muncie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-05-20 |
| Est. Completion | 2027-05 |
| Phase | NA |
What NCT07095426 shows while recruiting
NCT07095426 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 65-participant average among 119 other Healthy Participants trials with a reported enrollment target (69% lower).
The record links to 4 conditions, with Healthy Participants appearing as the primary indexed condition, and to 1 intervention - of which inulin is the first listed.
NCT07095426 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT07095426 about?
NCT07095426 is a clinical study titled "Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes". Based on prior research, the investigators are interested in whether an intervention targeting gut health (supplemental fiber for 9 weeks total) will improve vascular health in individuals with obesity. Additionally, the investigators are interested in if this response differs based on whether indiv...
What is the current status of trial NCT07095426?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-05-20. Estimated completion is 2027-05.
What conditions does trial NCT07095426 study?
This clinical trial studies the following conditions: Healthy Participants, Metabolic Syndrome, Metabolically Healthy Obesity, Metabolically Abnormal Obesity.
What interventions are being tested in trial NCT07095426?
The interventions under investigation include: inulin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07095426?
This trial is sponsored by Ball State University, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07095426 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Participants
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07095426's enrollment target sits among peer trials
20 91st of 119 higher than 26 of 119 other Healthy Participants trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Participants trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fructose Intestinal Gluconeogenesis
RECRUITING · NA
-
Royal Ancient Oats™ Study
RECRUITING · NA
-
The Increasing Mindfulness Engagement Project
RECRUITING · NA
-
Testing a Non-Invasive Spinal Stimulation Device
RECRUITING · NA
-
Glycemic/Insulinemic Effects of Fresh Mango as a Sugar Substitute in Realistic Breakfasts.
RECRUITING · NA
-
Effect of Limosilactobacillus Reuteri DSM 17648 in Healthy Adults Reporting Upper Gastrointestinal Discomfort
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI